Benitec Biopharma Files 8-K for Other Events
Ticker: BNTC · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1808898
| Field | Detail |
|---|---|
| Company | Benitec Biopharma INC. (BNTC) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing, other-events
TL;DR
Benitec Biopharma filed an 8-K for 'Other Events' on March 20, 2025. Details TBD.
AI Summary
On March 20, 2025, Benitec Biopharma Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." Specific details regarding the nature of these events, any associated financial implications, or definitive dates beyond the filing date are not elaborated upon in the provided text.
Why It Matters
This filing signals that Benitec Biopharma Inc. has reported significant events to the SEC, which could impact investors' understanding of the company's current status and future direction.
Risk Assessment
Risk Level: medium — The filing is for 'Other Events' without specific details, creating uncertainty about the nature and impact of these events.
Key Players & Entities
- Benitec Biopharma Inc. (company) — Registrant
- March 20, 2025 (date) — Date of Report
- 001-39267 (other) — Commission File Number
- 3940 Trust Way, Hayward, California 94545 (address) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Benitec Biopharma Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events'.
What is the significance of the filing date, March 20, 2025?
March 20, 2025, is the date of the report and the earliest event reported by Benitec Biopharma Inc.
What is Benitec Biopharma Inc.'s Commission File Number?
Benitec Biopharma Inc.'s Commission File Number is 001-39267.
Where are Benitec Biopharma Inc.'s principal executive offices located?
Benitec Biopharma Inc.'s principal executive offices are located at 3940 Trust Way, Hayward, California 94545.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Benitec Biopharma Inc. (BNTC).